Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to -$260000.0.

  • Krystal Biotech's Tax Provisions fell 10839.52% to -$260000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$15.3 million, marking a year-over-year decrease of 34810.5%. This contributed to the annual value of -$15.4 million for FY2025, which is 34786.19% down from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Tax Provisions is -$260000.0, which was down 10839.52% from -$31.4 million recorded in Q3 2025.
  • Krystal Biotech's 5-year Tax Provisions high stood at $8.4 million for Q2 2025, and its period low was -$31.4 million during Q3 2025.
  • In the last 3 years, Krystal Biotech's Tax Provisions had a median value of $2.3 million in 2023 and averaged -$897375.0.
  • Over the last 5 years, Krystal Biotech's Tax Provisions had its largest YoY gain of 166981.13% in 2025, and its largest YoY loss of 130769.23% in 2025.
  • Over the past 3 years, Krystal Biotech's Tax Provisions (Quarter) stood at $2.0 million in 2023, then soared by 57.61% to $3.1 million in 2024, then crashed by 108.4% to -$260000.0 in 2025.
  • Its Tax Provisions stands at -$260000.0 for Q4 2025, versus -$31.4 million for Q3 2025 and $8.4 million for Q2 2025.